IEC isolated from patients with non neoplastic disease provoked an increase in the proportion of activated CD8+CD38+ T-cell that was significantly blocked by the addition of anti-CD80 antibody, whereas no significant changes were observed in terms of CD4 activation. The gene discussed is CD8A; the disease is neoplasm.